But Johnson has reaped far more sales and profit from its other two divisions. Its pharmaceuticals division sells several blockbuster drugs., such as anemia drug Procit and schizophrenie drug Risperdal. A new drug, named Zytiga, prescribed to treat prostate cancer has been selling well. Its medical devices division is responsible for best-selling products such as Depuy orthopedic joint replacements and Cyper coronary stents. These two divisions tend to generate operating profit margins of around 30 percent, almost double those generated by the consumer business.